Document Detail

Clinical features of taxane neuropathy.
MedLine Citation:
PMID:  24300917     Owner:  NLM     Status:  Publisher    
Sensory neuropathy is the dose-limiting toxicity of paclitaxel and also impacts on the use of docetaxel and other taxanes. The cause of this adverse effect has to do with their mechanism of action against microtubules and its interaction with neuronal cytoskeletal components. The variability of this toxicity is defined by several factors including disease type, taxane class, schedule and dose of the specific drug, patient demographics, and use of taxanes in combination regimens (especially with the platinums that are also neurotoxic). Prevention of life-long neuropathy is only produced if the causative drug is halted - treatments to reverse toxicity have shown only minimal improvement. This review investigates trials defining the clinical factors that determine the therapeutic window of taxanes and the enhanced susceptibility to this toxicity. In addition, case vignettes illustrate the range of clinical manifestations of this toxicity during taxane administration.
David Kudlowitz; Franco Muggia
Related Documents :
25063227 - European perspective on multiple myeloma treatment strategies in 2014.
23922427 - Serial drug usage for tics in tourette syndrome - when to give up?
626987 - Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovaria...
23768657 - Drug induced complications; can we do more?
2024937 - Assessment of theophylline compliance in general practice using a 'compliance index' ba...
23597027 - Development and characterization of nanolipobeads-based dual drug delivery system for h...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-11-29
Journal Detail:
Title:  Anti-cancer drugs     Volume:  -     ISSN:  1473-5741     ISO Abbreviation:  Anticancer Drugs     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2013-12-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9100823     Medline TA:  Anticancer Drugs     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
aDepartment of Medicine, NYU Langone Medical Center bDepartment of Oncology, NYU Clinical Cancer Institute, New York, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Taxanes in combination with biologic agents for ovarian and breast cancers.
Next Document:  New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase.